Arbutus Biopharma Corp·4

Jun 26, 4:18 PM ET

Collier William H. 4

4 · Arbutus Biopharma Corp · Filed Jun 26, 2019

Insider Transaction Report

Form 4
Period: 2019-06-24
Collier William H.
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-06-24+1,112,0001,112,000 total
    Exercise: $2.18Exp: 2029-06-24Common Shares (1,112,000 underlying)
Footnotes (1)
  • [F1]The stock option will vest and become exercisable as to 25% of the common shares on June 24, 2020 and as to an additional 1/48th of the total original number of common shares subject to Mr. Collier's stock option on the corresponding day of each month over the three year period thereafter, subject to Mr. Collier's continued employment with Arbutus Biopharma Corporation through the applicable vesting dates.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT